StockWatch
·
Pharmaceuticals
Shareholding13 Jul 2026, 01:10 pm

Panacea Biotec: Promoter Group Acquires 2 Lakh Shares via Gift

AI Summary

Panacea Biotec Limited has filed a disclosure regarding an inter-se transfer of shares within the promoter group. Rajesh Jain (HUF) acquired 2,00,000 equity shares of the company from Dr. Rajesh Jain through a gift. This acquisition was made under Regulation 10(1)(a)(ii) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, for which an exemption report was submitted to SEBI on July 8, 2026. The transaction resulted in Rajesh Jain (HUF)'s shareholding increasing to 0.09% and Dr. Rajesh Jain's shareholding decreasing to 13.48%. The filing confirms compliance with relevant SEBI regulations.

Key Highlights

  • Rajesh Jain (HUF) acquired 2,00,000 shares via gift from Dr. Rajesh Jain.
  • Acquisition falls under SEBI SAST Regulations, Regulation 10(1)(a)(ii).
  • Promoter group shareholding adjusted post-transaction.
  • Exemption report filed with SEBI on July 8, 2026.
  • Transaction is an inter-se transfer within the promoter group.